Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition

YUMI YOKOTA, HIROAKI NOZAWA, HIROFUMI SONODA, YUICHIRO YOKOYAMA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI and SOICHIRO ISHIHARA
Anticancer Research August 2024, 44 (8) 3337-3342; DOI: https://doi.org/10.21873/anticanres.17153
YUMI YOKOTA
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI NOZAWA
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hiroanozawa{at}yahoo.co.jp
HIROFUMI SONODA
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHIRO YOKOYAMA
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIGENOBU EMOTO
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI MURONO
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHITO SASAKI
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOICHIRO ISHIHARA
Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 8 3337-3342
DOI 
https://doi.org/10.21873/anticanres.17153
PMID 
39060076

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 7, 2024
  • Revision received May 29, 2024
  • Accepted June 6, 2024
  • Published online July 26, 2024.

Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. YUMI YOKOTA,
  2. HIROAKI NOZAWA⇑,
  3. HIROFUMI SONODA,
  4. YUICHIRO YOKOYAMA,
  5. SHIGENOBU EMOTO,
  6. KOJI MURONO,
  7. KAZUHITO SASAKI and
  8. SOICHIRO ISHIHARA
  1. Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
  1. Correspondence to: Hiroaki Nozawa, MD, Ph.D., Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan. Tel: +81 33815-5411, e-mail: hiroanozawa{at}yahoo.co.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition
YUMI YOKOTA, HIROAKI NOZAWA, HIROFUMI SONODA, YUICHIRO YOKOYAMA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI, SOICHIRO ISHIHARA
Anticancer Research Aug 2024, 44 (8) 3337-3342; DOI: 10.21873/anticanres.17153

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition
YUMI YOKOTA, HIROAKI NOZAWA, HIROFUMI SONODA, YUICHIRO YOKOYAMA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI, SOICHIRO ISHIHARA
Anticancer Research Aug 2024, 44 (8) 3337-3342; DOI: 10.21873/anticanres.17153
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
  • Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
  • Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models
Show more Experimental Studies

Keywords

  • Indoleamine 2,3-dioxygenase
  • colorectal cancer
  • invasion
  • migration
  • epithelial-mesenchymal transition
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire